A high-throughput assay of NK cell activity in whole blood and its clinical application

Biochemical and Biophysical Research Communications

Volumn 445, Issue 3, 2014, Pages 584-590

  Lee, Saet byul ^a   Cha, Junhoe ^b   Kim, Im kyung ^a   Yoon, Joo Chun ^c   Lee, Hyo Joon ^a   Park, Sang Woo ^b   Cho, Sunjung ^b   Youn, Dong Ye ^b   Lee, Heyja ^b   Lee, Choong Hwan ^b   Lee, Jae Myun ^a   Lee, Kang Young ^a   Kim, Jongsun ^a  

^a Yonsei University College of Medicine   (South Korea)

^b ATGen   (South Korea)

^c Ewha Womans University School of Medicine   (South Korea)

Author keywords

ELISA; High throughput screening; IFN ; NK cell activity; Simple assay

Indexed keywords

GAMMA INTERFERON;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; CANCER STAGING; CELL ACTIVITY; CELL ASSAY; CELL ISOLATION; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; FEMALE; HIGH THROUGHPUT SCREENING; HUMAN; MALE; MICROSATELLITE STABLE COLORECTAL CANCER; MIDDLE AGED; MONOCYTE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ELISA; HIGH-THROUGHPUT SCREENING; IFN-Γ; NK CELL ACTIVITY; SIMPLE ASSAY;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; MALE; MIDDLE AGED;

EID: 84896313680     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.02.040     Document Type: Article

References (30)

1. Spits H., Di Santo J.P. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol 2011, 12:21-27.
2. Bryceson Y.T., Chiang S.C., Darmanin S., Fauriat C., Schlums H., Theorell J., Wood S.M. Molecular mechanisms of natural killer cell activation. J Innate Immun 2011, 3:216-226.
3. Langers I., Renoux V.M., Thiry M., Delvenne P., Jacobs N. Natural killer cells: role in local tumor growth and metastasis. Biologics 2012, 6:73-82.
4. Karre K., Ljunggren H.G., Piontek G., Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986, 319:675-678.
5. Ljunggren H.G., Malmberg K.J. Prospects for the use of NK cells in immunotherapy of human cancer. Nat Rev Immunol 2007, 7:329-339.
6. Smyth M.J., Hayakawa Y., Takeda K., Yagita H. New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer 2002, 2:850-861.
7. Yu T.K., Caudell E.G., Smid C., Grimm E.A. IL-2 activation of NK cells: involvement of MKK1/2/ERK but not p38 kinase pathway. J Immunol 2000, 164:6244-6251.
8. Martin-Fontecha A., Thomsen L.L., Brett S., Gerard C., Lipp M., Lanzavecchia A., Sallusto F. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 2004, 5:1260-1265.
9. Whiteside T.L., Friberg D. Natural killer cells and natural killer cell activity in chronic fatigue syndrome. Am J Med 1998, 105:27S-34S.
10. Konjevic G., Spuzic I. Stage dependence of NK cell activity and its modulation by interleukin 2 in patients with breast cancer. Neoplasma 1993, 40:81-85.
11. Tarle M., Kraljic I., Kastelan M. Comparison between NK cell activity and prostate cancer stage and grade in untreated patients: correlation with tumor markers and hormonal serotest data. Urol Res 1993, 21:17-21.
12. Takeuchi H., Maehara Y., Tokunaga E., Koga T., Kakeji Y., Sugimachi K. Prognostic significance of natural killer cell activity in patients with gastric carcinoma: a multivariate analysis. Am J Gastroenterol 2001, 96:574-578.
13. Corado J., Toro F., Rivera H., Bianco N.E., Deibis L., De Sanctis J.B. Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection. Clin Exp Immunol 1997, 109:451-457.
14. Kottilil S., Chun T.W., Moir S., Liu S., McLaughlin M., Hallahan C.W., Maldarelli F., Corey L., Fauci A.S. Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function. J Infect Dis 2003, 187:1038-1045.
15. Arkwright P.D., Abinun M., Cant A.J. Autoimmunity in human primary immunodeficiency diseases. Blood 2002, 99:2694-2702.
16. Prolo P., Chiappelli F., Angeli A., Dovio A., Perotti P., Pautasso M., Sartori M.L., Saba L., Mussino S., Fraccalini T., Fantó F., Mocellini C., Rosso M.G., Grasso E. Physiologic modulation of natural killer cell activity as an index of Alzheimer's disease progression. Bioinformation 2007, 1:363-366.
17. Patarca-Montero R., Antoni M., Fletcher M.A., Klimas N.G. Cytokine and other immunologic markers in chronic fatigue syndrome and their relation to neuropsychological factors. Appl Neuropsychol 2001, 8:51-64.
18. Moffett A., Regan L., Braude P. Natural killer cells, miscarriage, and infertility. BMJ 2004, 329:1283-1285.
19. Valiathan R., Lewis J.E., Melillo A.B., Leonard S., Ali K.H., Asthana D. Evaluation of a Flow Cytometry-Based Assay for Natural Killer Cell Activity in Clinical Settings. Scand J Immunol 2012, 75:455-462.
20. Alter G., Malenfant J.M., Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 2004, 294:15-22.
21. Claus M., Greil J., Watzl C. Comprehensive analysis of NK cell function in whole blood samples. J Immunol Methods 2009, 341:154-164.
22. Dowell A.C., Oldham K.A., Bhatt R.I., Lee S.P., Searle P.F. Long-term proliferation of functional human NK cells, with conversion of CD56(dim) NK cells to a CD56 (bright) phenotype, induced by carcinoma cells co-expressing 4-1BBL and IL-12. Cancer Immunol Immunother 2012, 61:615-628.
23. Alexander J., Watanabe T., Wu T.-T., Rashid A., Li S., Hamilton S.R. Histopathological Identification of Colon Cancer with Microsatellite Instability. Am J Pathol 2001, 158:527-536.
24. Hawkins D.M. Diagnostics for conformity of paired quantitative measurements. Stat Med 2002, 21:1913-1935.
25. Kawasaki-Oyama R.S., Braile D.M., Caldas H.C., Leal J.C., Goloni-Bertollo E.M., Pavarino-Bertelli E.C., Abbud S.I. Filho M. Blood mesenchymal stem cell culture from the umbilical cord with and without Ficoll-Paque density gradient method, Rev Bras Cir Cardiovasc 2008, 23:29-34.
26. Nagel J.E., Collins G.D. A. WH., Spontaneous or natural killer cytotoxicity of K562 erythroleukemic cells in normal patients. Cancer Res 1981, 41:2284-2288.
27. Thornton S., Kuhn K.A., Finkelman F.D., Hirsch R. NK cells secrete high levels of IFN-gamma in response to in vivo administration of IL-2. Eur J Immunol 2001, 31:3355-3360.
28. Flavell R.A., Sanjabi S., Wrzesinski S.H., Licona-Limon P. The polarization of immune cells in the tumour environment by TGFbeta. Nat Rev Immunol 2010, 10:554-567.
29. Imai K., Matsuyama S., Miyake S., Suga K., Nakachi K. Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence. an 11-year follow-up study of a general population. Lancet 2000, 356:1795-1799.
30. Friberg D.D., Bryant J.L., Whiteside T.L. Measurements of Natural Killer (NK) Activity and NK-Cell Quantification. Methods 1996, 9:316-326.